Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carl L. Gordon currently holds 90,000 shares of Compass Therapeutics, Inc. (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carl L. Gordon has been a net buyer of NONE stock. They have purchased $175.3M and sold $134.8M worth of shares.
Carl L. Gordon's most recent insider trade was on Jan 2, 2026, when they sold 90,000 shares at $0.00 per share.
Carl L. Gordon serves as Executive at Compass Therapeutics, Inc. (NONE). They have executed 255 insider transactions totaling $310.1M over their tenure at the company.
Carl L. Gordon holds the position of Executive at Compass Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Carl L. Gordon has shown a buying trading pattern, with $175.3M in total purchases and $134.8M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Carl L. Gordon was on Aug 13, 2024, when they sold $9.7M worth of KROS shares. This transaction involved 220,600 shares at $44.01 per share.
Carl L. Gordon currently owns 90,000 shares of Compass Therapeutics, Inc. (NONE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carl L. Gordon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carl L. Gordon has 255 Form 4 filings on record as an insider at Compass Therapeutics, Inc..
Set alerts for Carl L. Gordon and 40,000+ other insiders.